Navigation Links
StoredIQ Shares Expertise at IQPC's eDiscovery Pharma, Biotech and Medical Device Conference
Date:9/10/2009

ies
  • Matching the right system with the right internal team

    • HOW: For more information about the conference and to register, visit: www.ediscoveryevent.com/pharma/

    About StoredIQ

    StoredIQ is a leading provider of enterprise-class Intelligent Information Management solutions, enabling organizations to gain visibility and control over business-critical information to help meet their compliance, governance and legal discovery requirements. The company provides a range of integrated solutions for fast response to litigation and investigations, for proactive "litigation readiness," and for information protection and risk management, as well as storage management. Industry-leading companies rely on StoredIQ's award-winning technology to streamline their information management and eDiscovery processes to reduce the risk, complexity and cost of litigation. For more information, visit www.storediq.com.

    StoredIQ is a trademark of StoredIQ, Inc. All other trademarks may or may not be trademarks or registered trademarks of their respective owners.


    '/>"/>
    SOURCE StoredIQ
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2

    Related biology technology :

    1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
    2. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
    3. Neuralstem Shares Accepted for Trading on Amex(R)
    4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
    5. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
    6. Essilor Cancels 700,000 Shares
    7. Helix BioPharma announces $16.9 million private placement of common shares
    8. Helix BioPharma closes $16.9 million private placement of common shares
    9. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
    10. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
    11. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Breaking Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6
    Breaking Biology News(10 mins):The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 1Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 2Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 3Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 4Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 57361 1Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 57361 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 1CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 3